Inventor · disambiguated record
Jiangchao Yao
Also filed as: YAO JIANGCHAO
50 granted patents·9 pending applications·305 citations·filing 2006–2022
98Inventor score
Files withPURDUE PHARMA LP32VENATORX PHARMACEUTICALS INC11CHEN ZHENGMING3MATSUMURA AKIRA3KYLE DONALD J2
Top patents by PatentIndex Score
59 records- 0197US9181185B2Heteroaryl compounds as sodium channel blockersPURDUE PHARMA LP·Filed 2012·Granted Nov 10, 2015·20 cites·20 claims
- 0296US9168255B2Quinazoline compounds as sodium channel blockersPURDUE PHARMA LP·Filed 2015·Granted Oct 27, 2015·25 cites·20 claims
- 0394US9206127B2Substituted pyridines as sodium channel blockersPURDUE PHARMA LP·Filed 2013·Granted Dec 8, 2015·24 cites·21 claims
- 0494US8476271B2Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulatorsTSUNO NAOKI·Filed 2011·Granted Jul 2, 2013·30 cites·51 claims
- 0593US11566001B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·2 cites·11 claims
- 0693US9212139B2Aryl substituted indoles and their use as blockers of sodium channelsKYLE DONALD J·Filed 2011·Granted Dec 15, 2015·22 cites·61 claims
- 0793US9056832B2Pyridine compounds and the users thereofNI CHIYOU·Filed 2011·Granted Jun 16, 2015·26 cites·14 claims
- 0892US10590076B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Mar 17, 2020·6 cites·17 claims
- 0992US9145408B2Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulatorsPURDUE PHARMA LP·Filed 2013·Granted Sep 29, 2015·13 cites·78 claims
- 1090US9045435B2Quinazoline compounds as sodium channel blockersGOEHRING R RICHARD·Filed 2011·Granted Jun 2, 2015·25 cites·50 claims
- 1190US8969358B2Buprenorphine analogsPURDUE PHARMA LP·Filed 2014·Granted Mar 3, 2015·19 cites·20 claims
- 1287US10399996B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Sep 3, 2019·6 cites·17 claims
- 1387US10005768B2Carboxamide derivatives and use thereofPURDUE PHARMA LP·Filed 2016·Granted Jun 26, 2018·5 cites·19 claims
- 1487US9493449B2Carboxamide derivatives and use thereofPURDUE PHARMA LP·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
- 1587US9382260B2Buprenorphine analogsPURDUE PHARMA LP·Filed 2015·Granted Jul 5, 2016·6 cites·15 claims
- 1687US9056836B2Benzomorphan analogs and the use thereofPURDUE PHARMA LP·Filed 2014·Granted Jun 16, 2015·12 cites·22 claims
- 1786US9656959B2Substituted pyridines as sodium channel blockersNI CHIYOU·Filed 2011·Granted May 23, 2017·11 cites·24 claims
- 1884US9278967B2Substituted-quinoxaline-type piperidine compounds and the uses thereofPURDUE PHARMA LP·Filed 2014·Granted Mar 8, 2016·6 cites·20 claims
- 1984US9090618B2Substituted benzimidazole-type piperidine compounds and uses thereofPURDUE PHARMA LP·Filed 2013·Granted Jul 28, 2015·3 cites·47 claims
- 2083US11267826B2Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Mar 8, 2022·2 cites·20 claims
- 2182US8846929B2Substituted-quinoxaline-type piperidine compounds and the uses thereofFUCHINO KOUKI·Filed 2010·Granted Sep 30, 2014·9 cites·111 claims
- 2281US11046716B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Jun 29, 2021·1 cites·20 claims
- 2381US9527840B2Substituted-quinoxaline-type piperidine compounds and the uses thereofPURDUE PHARMA LP·Filed 2016·Granted Dec 27, 2016·3 cites·20 claims
- 2480US10059675B2Pyrimidines as sodium channel blockersPURDUE PHARMA LP·Filed 2017·Granted Aug 28, 2018·2 cites·21 claims
- 2579US11014881B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted May 25, 2021·1 cites·17 claims
- 2678US8247442B2Benzenesulfonamide compounds and their useCHEN ZHENGMING·Filed 2007·Granted Aug 21, 2012·4 cites·36 claims
- 2777US9828348B2Benzimidazole derivatives and use thereofPURDUE PHARMA LP·Filed 2014·Granted Nov 28, 2017·1 cites·10 claims
- 2877US9611222B2Pyridine compounds and the uses thereofPURDUE PHARMA LP·Filed 2015·Granted Apr 4, 2017·2 cites·19 claims
- 2977US2023062975A1Hepatitis b capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3075US9890164B2Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulatorsPURDUE PHARMA LP·Filed 2015·Granted Feb 13, 2018·1 cites·25 claims
- 3175US8399486B2Benzenesulfonyl compounds and the use thereofKYLE DONALD J·Filed 2008·Granted Mar 19, 2013·2 cites·51 claims
- 3275US8193208B2Fused and spirocycle compounds and the use thereofCHEN ZHENGMING·Filed 2006·Granted Jun 5, 2012·2 cites·19 claims
- 3373US11111246B2Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compoundsPURDUE PHARMA LP·Filed 2019·Granted Sep 7, 2021·0 cites·5 claims
- 3472US9637458B2Pyrimidine carboxamides as sodium channel blockersLOCKMAN JEFFREY·Filed 2014·Granted May 2, 2017·3 cites·19 claims
- 3570US11247965B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Feb 15, 2022·1 cites·18 claims
- 3670US10730866B2Indole derivatives and use thereofPURDUE PHARMA LP·Filed 2015·Granted Aug 4, 2020·1 cites·8 claims
- 3767US10519156B29′-Aza[3,9′-bi(bicyclo[3.3.1]nonan)]-3′-one and preparation thereofPURDUE PHARMA LP·Filed 2018·Granted Dec 31, 2019·0 cites·5 claims
- 3866US9975854B2Benzomorphan analogs and use thereofPURDUE PHARMA LP·Filed 2015·Granted May 22, 2018·1 cites·17 claims
- 3965US10774050B2Pyrimidines as sodium channel blockersPURDUE PHARMA LP·Filed 2018·Granted Sep 15, 2020·0 cites·21 claims
- 4063US10202344B2Aryl substituted indoles and the use thereofPURDUE PHARMA LP·Filed 2017·Granted Feb 12, 2019·0 cites·15 claims
- 4163US2019292149A1Aryl substituted indoles and the use thereofPURDUE PHARMA LP·Filed 2019·Application pending·0 cites
- 4262US11834447B2Indole derivatives and use thereofPURDUE PHARMA LP·Filed 2020·Granted Dec 5, 2023·0 cites·16 claims
- 4362US2018148449A1Substituted-Quinoxaline-Type Bridged-Piperidine Compounds and the Uses ThereofPURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 4459US9975858B2Benzimidazole derivatives and use thereofPURDUE PHARMA LP·Filed 2017·Granted May 22, 2018·0 cites·15 claims
- 4557US2024018166A1Sulfonyl urea nlrp3 inflammasome inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4655US9624194B2Heteroaryl compounds as sodium channel blockersPURDUE PHARMA LP·Filed 2015·Granted Apr 18, 2017·0 cites·22 claims
- 4753US2016326111A1Aryl substituted indoles and the use thereofPURDUE PHARMA LP·Filed 2015·Application pending·0 cites
- 4853US2023127898A1Hepatitis b capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4952US2023107941A1Hepatitis b capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 5051US9598411B2Substituted benzimidazole-type piperidine compounds and uses thereofPURDUE PHARMA LP·Filed 2015·Granted Mar 21, 2017·0 cites·22 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jiangchao Yao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →